Active, Not Recruiting
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy
NCT05949593
- Conditions
- Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
- Locations
-
- Belite Study Site Phoenix, Arizona, United States
- Belite Study Site Arcadia, California, United States
- Belite Study Site Beverly Hills, California, United States
- Belite Study Site Huntington Beach, California, United States